Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2025-12-25 @ 2:13 PM
Study NCT ID:
NCT07295366
Status:
RECRUITING
Last Update Posted:
2025-12-19
First Post:
2025-12-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Randomized, Open-label, Blinded Endpoint Assessment Study of Early PCSK9 Inhibitor Administration After Thrombectomy in Patients With Atherosclerotic Acute Ischemic Stroke.
Sponsor:
The Affiliated Hospital of Xuzhou Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-18
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-07
First Submit QC Date:
None
Study First Post Date:
2025-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-08
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED